These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12950510)

  • 21. Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD.
    Kardos P; Worsley S; Singh D; Román-Rodríguez M; Newby DE; Müllerová H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2885-2895. PubMed ID: 27932872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 23. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
    Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
    Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of large scale clinical trials and their application to usual practice.
    Tonkin AM
    Heart; 2000 Dec; 84(6):679-84. PubMed ID: 11083755
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 26. The end of biomedical journals: there is madness in their methods.
    Aickin M
    J Altern Complement Med; 2005 Oct; 11(5):755-7. PubMed ID: 16296895
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence-Based Medicine and Rare Diseases.
    Day S
    Adv Exp Med Biol; 2017; 1031():207-220. PubMed ID: 29214574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating patient exclusion bias in meta-analysis.
    Tierney JF; Stewart LA
    Int J Epidemiol; 2005 Feb; 34(1):79-87. PubMed ID: 15561753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recommendations for prevention and evidence-based medicine].
    Gohlke H; Schuler G
    Z Kardiol; 2005; 94 Suppl 3():III/1-5. PubMed ID: 16258784
    [No Abstract]   [Full Text] [Related]  

  • 30. DAMASCENE and Meta-Ecological Research: A Bridge Too Far.
    Moyé L
    Circ Res; 2014 Aug; 115(5):484-7. PubMed ID: 25006188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The case for practical clinical trials in psychiatry.
    March JS; Silva SG; Compton S; Shapiro M; Califf R; Krishnan R
    Am J Psychiatry; 2005 May; 162(5):836-46. PubMed ID: 15863782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empirical evaluation of age groups and age-subgroup analyses in pediatric randomized trials and pediatric meta-analyses.
    Contopoulos-Ioannidis DG; Seto I; Hamm MP; Thomson D; Hartling L; Ioannidis JP; Curtis S; Constantin E; Batmanabane G; Klassen T; Williams K
    Pediatrics; 2012 Jun; 129 Suppl 3():S161-84. PubMed ID: 22661763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Selection Bias on Treatment Effect Size Estimates in Randomized Trials of Oral Health Interventions: A Meta-epidemiological Study.
    Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
    J Dent Res; 2018 Jan; 97(1):5-13. PubMed ID: 28813182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of systematic reviews and meta-analyses in pediatric nutrition.
    Szajewska H
    World Rev Nutr Diet; 2013; 108():1-10. PubMed ID: 24029781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks of guidelines in medicine.
    Lübbe AS
    Onkologie; 2004 Jun; 27(3):316-8. PubMed ID: 15249724
    [No Abstract]   [Full Text] [Related]  

  • 36. [Could homeopathy find its legitimacy in the "positive" results of a meta-analysis?].
    Scheen AJ
    Rev Med Liege; 1997 Nov; 52(11):694-7. PubMed ID: 9480493
    [No Abstract]   [Full Text] [Related]  

  • 37. [How to assess the quality of systematic review and meta-analysis].
    Zhang JH; Shang HC; Zhang BL
    Zhong Xi Yi Jie He Xue Bao; 2008 Apr; 6(4):337-40. PubMed ID: 18405597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal research as a basis for clinical trials.
    Faggion CM
    Eur J Oral Sci; 2015 Apr; 123(2):61-4. PubMed ID: 25684017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of meta-analysis in monitoring clinical trials.
    Begg CB
    Stat Med; 1996 Jun; 15(12):1299-306; discussion 1307-11. PubMed ID: 8817803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes.
    Tanniou J; van der Tweel I; Teerenstra S; Roes KC
    BMC Med Res Methodol; 2016 Feb; 16():20. PubMed ID: 26891992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.